オハイオにおける非筋層浸潤性膀胱癌の臨床試験
オハイオ内の拠点で、非筋層浸潤性膀胱癌に関する13件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- TriState Urologic Services PSC Inc. dba The Urology Group ( Site 0122), Cincinnati
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- The James at Brain and Spine Hospital (OSU), Columbus
- Oregon Urology Institute, Springfield
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Dayton Physicians Network Urology, Centerville
- Central Ohio Urology Group, Gahanna
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06919965Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05796375Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Cleveland Clinic Main Campus, Cleveland, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/24更新 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Cincinnati Medical Center (UCMC), Cincinnati
- The Ohio State University (OSU), Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of Cincinnati Medical Center, Cincinnati
- Central Ohio Urology Group, Gahanna
- Clinical Research Solutions - Helios Clinical Research, Middleburg Heights
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/07更新 · NCT04752722Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
- The Ohio State University, Columbus
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/31更新 · NCT07225127A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- The Ohio State University, Columbus
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/27更新 · NCT05710848Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第4相
18歳以上 · 全性別 · 2026/03/16更新 · NCT07474519Blue Light Cystoscopy With Cysview® Registry
- Ohio State University Wexner Medical Center, Columbus
- Ohio State University, Columbus
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT02660645Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-017 - Central Ohio Urology Group, Gahanna
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/24更新 · NCT03945162ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。